Barts-MINOCA Registry

Launched by QUEEN MARY UNIVERSITY OF LONDON · Jun 17, 2020

Keywords

ClinConnect Summary

The Barts-MINOCA Registry is a clinical trial focused on understanding a specific type of heart attack called myocardial infarction with non-obstructive coronary arteries, or MINOCA. This condition affects 1 to 13% of patients who experience a heart attack, but it can be tricky to diagnose and treat because the standard treatment, which involves opening blocked arteries, is not suitable for these patients. The study aims to gather more information about MINOCA, especially since current guidelines for managing this condition are lacking, and many questions about the best ways to care for these patients remain unanswered.

To participate in this trial, individuals must be at least 16 years old and have been diagnosed with MINOCA, meaning they have elevated levels of a protein called troponin, which indicates heart damage, but no clear cause for this rise has been identified. The trial is currently recruiting participants of all genders and ages over 16. Those who join can expect to contribute to important research that could help improve treatment options for future patients with similar heart issues. Remember, this study is crucial for finding better ways to understand and manage this complex condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Both male and female patients ≥16 years of age will be included
• • All patients will have a diagnosis MINOCA. Any patient who does not have a clear cause of troponin rise
• Exclusion Criteria:
• • Patients \<16 years will not be included in this study.